HLA alleles and amino-acid signatures of the peptide-binding pockets of HLA molecules in vitiligo

Journal of Investigative Dermatology

Volumn 132, Issue 1, 2012, Pages 124-134

  Singh, Archana ^a   Sharma, Pankaj ^b   Kar, Hemanta K ^b   Sharma, Vinod K ^c   Tembhre, Manoj K ^c   Gupta, Somesh ^c   Laddha, Naresh C ^d   Dwivedi, Mitesh ^d   Begum, Rasheedunnisa ^d   Gokhale, Rajesh S ^a,e   Rani, Rajni ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d M S UNIVERSITY OF BARODA   (India)

^e CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HAPLOTYPE; HLA SYSTEM; HUMAN; INDIA; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MELANOCYTE; PRIORITY JOURNAL; VITILIGO;

EID: 84856112855     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.240     Document Type: Article

References (43)

1. Alkhateeb A, Fain PR, Thody A et al. (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16:208-14 (Pubitemid 36597056)
2. Bettencourt BF, Santos MR, Fialho RN et al. (2008) Evaluation of two methods for computational HLA haplotypes inference using a real dataset. BMC Bioinformatics 9:68
3. Bhatia PS, Mohan L, Pandey ON et al. (1992) Genetic nature of vitiligo. J Dermatol Sci 4:180-4 (Pubitemid 23017815)
4. Buc M, Fazekasova H, Cechova E et al. (1998) Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo. Eur J Dermatol 8:13-5 (Pubitemid 28264142)
5. Consortium IGV (2005) The Indian Genome Variation database (IGVdb): a project overview. Hum Genet 118:1-11
6. Das SK, Majumder PP, Chakraborty R et al. (1985) Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol 2:71-8 (Pubitemid 15101651)
7. De Vijlder HC, Westerhof W, Schreuder GM et al. (2004) Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res 17:270-4 (Pubitemid 38724557)
8. Dell'anna ML, Picardo M (2006) A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res 19:406-11 (Pubitemid 44326402)
9. Excoffier L, Laval G, Schneider S (2005) Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1:47-50
10. Excoffier L, Slatkin M (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921-7
11. Falk K, Rotzschke O, Stevanovic S et al. (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290-6 (Pubitemid 21896578)
12. Haldane JB (1956) The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20:309-11
13. Handa S, Kaur I (1999) Vitiligo: clinical findings in 1436 patients. J Dermatol 26:653-7 (Pubitemid 29510347)
14. Horton R, Wilming L, Rand V et al. (2004) Gene map of the extended human MHC. Nat Rev Genet 5:889-99 (Pubitemid 39564252)
15. Israni N, Goswami R, Kumar A et al. (2009) Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India. PLoS One 4:e8023
16. Jin Y, Birlea SA, Fain PR et al. (2010) Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med 362:1686-97
17. Kemp EH, Waterman EA, Weetman AP (2001) Immunological pathomechanisms in vitiligo. Expert Rev Mol Med 3:1-22
18. Kovacs SO (1998) Vitiligo. J Am Acad Dermatol 38:647-66 (Pubitemid 28214006)
19. Lang KS, Caroli CC, Muhm A et al. (2001) HLA-A2 restricted, melanocytespecific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J Invest Dermatol 116:891-7 (Pubitemid 32554374)
20. Lerner AB (1971) On the etiology of vitiligo and gray hair. Am J Med 51:141-7
21. Liu JB, Li M, Chen H et al. (2007) Association of vitiligo with HLA-A2: a meta-analysis. J Eur Acad Dermatol Venereol 21:205-13 (Pubitemid 46128696)
22. Majumder PP, Nordlund JJ, Nath SK (1993) Pattern of familial aggregation of vitiligo. Arch Dermatol 129:994-8 (Pubitemid 23238604)
23. Marsh SG, Albert ED, Bodmer WF et al. (2010) Nomenclature for factors of the HLA system, 2010. Tissue Antigens 75:291-455
24. Menconi F, Osman R, Monti MC et al. (2010) Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Proc Natl Acad Sci USA 107:16899-903
25. Orozco-Topete R, Cordova-Lopez J, Yamamoto-Furusho JK et al. (2005) HLA-DRB1 *04 is associated with the genetic susceptibility to develop vitiligo in Mexican patients with autoimmune thyroid disease. J Am Acad Dermatol 52:182-3 (Pubitemid 40038976)
26. Quan C, Ren YQ, Xiang LH et al. (2010) Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet 42:614-8
27. Rani R, Fernandez-Vina MA, Stastny P (1998) Associations between HLA class II alleles in a North Indian population. Tissue Antigens 52:37-43 (Pubitemid 28327723)
28. Rani R, Sood A, Goswami R (2004) Molecular basis of predisposition to develop type 1 diabetes mellitus in North Indians. Tissue Antigens 64:145-55 (Pubitemid 38969578)
29. Ren Y, Yang S, Xu S et al. (2009) Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo. PLoS Genet 5:e1000523
30. Schwartz RA, Janniger CK (1997) Vitiligo. Cutis 60:239-44 (Pubitemid 127473333)
31. Shajil EM, Chatterjee S, Agrawal D et al. (2006) Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes. Indian J Exp Biol 44:526-39 (Pubitemid 44049404)
32. Sidney J, Peters B, Frahm N et al. (2008) HLA class I supertypes: a revised and updated classification. BMC Immunol 9:1
33. Taieb A, Picardo M (2007) The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 20:27-35 (Pubitemid 46090162)
34. Tastan HB, Akar A, Orkunoglu FE et al. (2004) Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population. Pigment Cell Res 17:181-4 (Pubitemid 38419646)
35. Todd JA, Bell JI, McDevitt HO (1987) HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604 (Pubitemid 17140111)
36. Van den Boorn JG, Konijnenberg D, Dellemijn TA et al. (2009) Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 129:2220-32
37. Wankowicz-Kalinska A, van den Wijngaard RM, Tigges BJ et al. (2003) Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest 83:683-95 (Pubitemid 36618047)
38. Waterman EA, Gawkrodger DJ, Watson PF et al. (2010) Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library. J Invest Dermatol 130:230-40
39. Winchester R (1994) The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 56:389-466 (Pubitemid 24242228)
40. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251-3
41. Zamani M, Spaepen M, Sghar SS et al. (2001) Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol 145: 90-4 (Pubitemid 32862792)
42. Zhang XJ, Liu HS, Liang YH et al. (2004a) Association of HLA class I alleles with vitiligo in Chinese Hans. J Dermatol Sci 35:165-8
43. Zhang XJ, Liu JB, Gui JP et al. (2004b) Characteristics of genetic epidemiology and genetic models for vitiligo. J Am Acad Dermatol 51:383-90